Cumulative IgE-levels specific for respiratory allergens as biomarker to predict efficacy of anti-IgE-based treatment of severe asthma

Cumulative IgE-levels specific for respiratory allergens as biomarker to predict efficacy of anti-IgE-based treatment of severe asthma

Molecular therapies, including anti-IgE, biologicals and small molecules are increasingly used for treatment of asthma. The effectiveness of these therapies may be increased with biomarkers. Aim of this study was to assess the value of measuring cumulative IgE levels specific for respiratory allerge...

Full description

Bibliographic Details
Main Authors: Veronika Naumova, Evgeny Beltyukov, Katarzyna Niespodziana, Peter Errhalt, Rudolf Valenta, Alexander Karaulov, Darina Kiseleva
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Immunology
Subjects:
asthma biomarker
Omalizumab
biologicals
molecular therapy
targeted therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.941492/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.941492/full

Similar Items